These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35132603)

  • 1. Cytokine Storm and Failed Resolution in COVID-19: Taking a Cue from Multiple Sclerosis.
    Zahoor I; Li Y; Rattan R; Giri S
    Adv Exp Med Biol; 2021; 1352():211-222. PubMed ID: 35132603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.
    Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V
    Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and cancer: start the resolution!
    Barksdale C; Kipper FC; Tripathy S; Subbian S; Serhan CN; Panigrahy D
    Cancer Metastasis Rev; 2022 Mar; 41(1):1-15. PubMed ID: 35190921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specialized pro-resolving lipid mediators regulate inflammatory macrophages: A paradigm shift from antibiotics to immunotherapy for mitigating COVID-19 pandemic.
    Kumar V; Yasmeen N; Chaudhary AA; Alawam AS; Al-Zharani M; Suliman Basher N; Harikrishnan S; Goud MD; Pandey A; Lakhawat SS; Sharma PK
    Front Mol Biosci; 2023; 10():1104577. PubMed ID: 36825200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavonoids against the SARS-CoV-2 induced inflammatory storm.
    Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P
    Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the
    Arnardottir H; Pawelzik SC; Öhlund Wistbacka U; Artiach G; Hofmann R; Reinholdsson I; Braunschweig F; Tornvall P; Religa D; Bäck M
    Front Physiol; 2020; 11():624657. PubMed ID: 33505321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature.
    Pedrosa AR; Martins DC; Rizzo M; Silva-Nunes J
    J Diabetes Complications; 2023 Feb; 37(2):108391. PubMed ID: 36621213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis.
    Dziedzic A; Saluk-Bijak J; Miller E; Niemcewicz M; Bijak M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaconutrition strategy to resolve SARS-CoV-2-induced inflammatory cytokine storm in non-alcoholic fatty liver disease: Omega-3 long-chain polyunsaturated fatty acids.
    Jeyakumar SM; Vajreswari A
    World J Clin Cases; 2021 Nov; 9(31):9333-9349. PubMed ID: 34877270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.
    Zahoor I; Giri S
    Clin Rev Allergy Immunol; 2021 Apr; 60(2):147-163. PubMed ID: 32495237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for precision nutrition, genetic variation and resolution in Covid-19 patients.
    Simopoulos AP; Serhan CN; Bazinet RP
    Mol Aspects Med; 2021 Feb; 77():100943. PubMed ID: 33551236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
    Front Immunol; 2021; 12():749291. PubMed ID: 34867978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
    Ahmed F
    Front Immunol; 2020; 11():590459. PubMed ID: 33362771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
    López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
    Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms and potential therapeutic targets of hyperinflammatory responses in SARS-CoV-2.
    Chukwuma IF; Apeh VO; Chiletugo OF
    Acta Virol; 2021; 65(1):3-9. PubMed ID: 33112637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.